InVivo Therapeutics Corporation Appoints Lorianne Masuoka, MD As Chief Medical Officer

InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Lorianne Masuoka, MD, as Chief Medical Officer (CMO), effective March 2, 2015. She will be taking over for the interim CMO, Lou Vaickus, MD, who is also Founder & President of akta Pharmaceutical Development LLC, a life sciences consulting company.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC